Efmoroctocog alfa for hemophilia A: Added benefit not proven
Monday, April 4, 2016 - 12:30
in Health & Medicine
Regarding Efmoroctocog alfa for hemophilia A, reviewers found that no added benefit can be derived. Type A hemophilia is an inherited disorder that impairs blood clotting.